Get the Stockscreener App
5.03
1.57%
-0.08
After Hours:
5.04
0.010
+0.20%
Puma Biotechnology Inc stock is traded at $5.03, with a volume of 430.63K.
It is down -1.57% in the last 24 hours and up +56.21% over the past month.
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
See More
Previous Close:
$5.11
Open:
$5.16
24h Volume:
430.63K
Relative Volume:
0.78
Market Cap:
$253.36M
Revenue:
$230.47M
Net Income/Loss:
$30.28M
P/E Ratio:
8.2459
EPS:
0.61
Net Cash Flow:
$38.86M
1W Performance:
-0.20%
1M Performance:
+56.21%
6M Performance:
+42.09%
1Y Performance:
+118.70%
1-Day Range:
$4.985
$5.22
1-Week Range:
$4.93
$5.44
52-Week Range:
$2.225
$6.07
Puma Biotechnology Inc Stock (PBYI) Company Profile
Name
Puma Biotechnology Inc
Sector
Industry
Phone
(424) 248-6500
Address
10880 WILSHIRE BLVD., LOS ANGELES, CA
Compare PBYI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
5.03 | 257.39M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Underperform |
| Oct-08-19 | Downgrade | Goldman | Neutral → Sell |
| May-10-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-10-19 | Downgrade | Citigroup | Buy → Neutral |
| Jan-17-19 | Initiated | Leerink Partners | Mkt Perform |
| Jan-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-19-18 | Upgrade | Goldman | Sell → Neutral |
| Nov-02-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Nov-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-17-18 | Initiated | Goldman | Sell |
| May-11-18 | Reiterated | Stifel | Buy |
| Nov-10-17 | Reiterated | Citigroup | Buy |
| Nov-10-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-02-17 | Reiterated | Stifel | Buy |
| Sep-11-17 | Reiterated | Credit Suisse | Outperform |
| Jul-10-17 | Resumed | Leerink Partners | Outperform |
| Jun-06-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-25-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Mar-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Puma Biotechnology Inc Stock (PBYI) Latest News
What moving averages say about Puma Biotechnology Inc.2025 Market WrapUp & Verified Momentum Stock Watchlist - Newser
Is Puma Biotechnology Inc. stock a top performer YTDWeekly Stock Report & Intraday High Probability Setup Alerts - 강소기업뉴스
Can Puma Biotechnology Inc. sustain its profitabilityJuly 2025 Action & Weekly Setup with ROI Potential - خودرو بانک
What is Puma Biotechnology Inc. s revenue forecastBull Run & Expert Approved Momentum Trade Ideas - خودرو بانک
Can Puma Biotechnology Inc. navigate macro headwindsJuly 2025 Outlook & Reliable Price Action Trade Plans - خودرو بانک
Will earnings trigger a reversal in Puma Biotechnology Inc.July 2025 Big Picture & Weekly Market Pulse Updates - Newser
Should you hold or exit Puma Biotechnology Inc. nowJuly 2025 Selloffs & Fast Entry and Exit Trade Plans - Newser
Visualizing Puma Biotechnology Inc. stock with heatmapsJuly 2025 Outlook & AI Optimized Trade Strategies - Newser
What dividend growth rate does Puma Biotechnology Inc. offer2025 Fundamental Recap & Stock Portfolio Risk Management - خودرو بانک
Heatmap analysis for Puma Biotechnology Inc. and competitorsWeekly Profit Report & Daily Stock Momentum Reports - Newser
How to interpret RSI for Puma Biotechnology Inc. stock2025 Stock Rankings & Safe Entry Trade Reports - Newser
What’s the beta of Puma Biotechnology Inc. stockForecast Cut & Community Trade Idea Sharing - خودرو بانک
Earnings visualization tools for Puma Biotechnology Inc.Bear Alert & Fast Gain Swing Alerts - Newser
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)September 4, 2025 - biospace.com
Can momentum traders help lift Puma Biotechnology Inc.2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
Puma Biotechnology's Strategic Use of Equity Incentives to Drive Talent and Growth - AInvest
Puma Biotechnology reports inducement awards under Nasdaq listing rule 5635(c)(4) - MarketScreener
Are Strong Financial Prospects The Force That Is Driving The Momentum In Puma Biotechnology, Inc.'s NASDAQ:PBYI) Stock? - Yahoo Finance
Detecting support and resistance levels for Puma Biotechnology Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Long term hold vs stop loss in Puma Biotechnology Inc.July 2025 Breakouts & AI Enhanced Trade Execution Alerts - Newser
Strategies to average down on Puma Biotechnology Inc.Watch List & Daily Market Momentum Tracking - Newser
Short interest data insights for Puma Biotechnology Inc.Trade Ideas & Daily Oversold Bounce Ideas - Newser
How to build a dashboard for Puma Biotechnology Inc. stock2025 Price Action Summary & Step-by-Step Trade Execution Guides - Newser
Can Puma Biotechnology Inc. sustain earnings growthWeekly Trade Review & Fast Gain Stock Trading Tips - خودرو بانک
Does Puma Biotechnology Inc. have strong fundamentalsJuly 2025 Technicals & Long-Term Growth Stock Strategies - خودرو بانک
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
When is the best time to exit Puma Biotechnology Inc.Earnings Recap Report & Daily Profit Focused Screening - Newser
Has Puma Biotechnology Inc. found a price floorEarnings Summary Report & Verified High Yield Trade Plans - Newser
Puma Biotechnology Inc. recovery potential after sell offJuly 2025 Intraday Action & Expert Verified Movement Alerts - Newser
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference - biospace.com
Applying sector rotation models to Puma Biotechnology Inc.Trade Entry Report & Consistent Profit Alerts - Newser
Is Now a Good Time to Reenter Puma Biotechnology Inc.2025 Market Overview & Free Weekly Watchlist of Top Performers - beatles.ru
What does recent volatility data suggest for Puma Biotechnology Inc.2025 Macro Impact & AI Driven Stock Movement Reports - Newser
Biotech Leader Puma's CEO Alan Auerbach to Share Company Vision at H.C. Wainwright Global Conference - Stock Titan
Earnings Report: Can Puma Biotechnology Inc. sustain its profitabilityTrade Performance Summary & Real-Time Stock Entry Alerts - خودرو بانک
Has Puma Biotechnology Inc. formed a bullish divergenceQuarterly Market Review & Fast Gain Swing Alerts - Newser
Is Puma Biotechnology Inc. showing signs of accumulationPortfolio Return Report & Verified Chart Pattern Trade Signals - Newser
What momentum shifts mean for Puma Biotechnology Inc.Market Trend Review & Technical Buy Zone Confirmations - Newser
Published on: 2025-09-02 12:47:01 - خودرو بانک
Puma Biotechnology Inc. Facing Inflection Point in Trend AnalysisJuly 2025 Short Interest & Weekly High Momentum Picks - beatles.ru
Price Channel Expanding on Puma Biotechnology Inc.’s Chart getLinesFromResByArray error: size == 0 - 강소기업뉴스
Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Analyzing net buyer seller activity in Puma Biotechnology Inc.Swing Trade & Real-Time Volume Triggers - Newser
Traders Watching For Reversal Pattern in Puma Biotechnology Inc.Portfolio Return Report & Fast Entry Momentum Alerts - beatles.ru
Puma Biotechnology Inc Stock (PBYI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):